Kingstone Capital Partners Texas’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,318	Closed	-$230K	–	61
2025 Q1	$230K	Hold	3,318	–	–	0.19%	44
2024 Q4	$285K	Buy	+3,318	New	+$285K	0.23%	40